SRPT - Wall Street Estimates - Sarepta Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 115.69

1.08 %

$ 11.1 B

Market Cap

75.12

P/E

Price Target Average

55.24%

Revenue Forecast Estimate

52.74%

EBIT Estimate

--126.29%

Net Income Estimate

68.02%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Sarepta Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for SRPT of $180 , with forecasts ranging from a low of $141 to a high of $205 .

SRPT Lowest Price Target Wall Street Target

141 USD 21.88%

SRPT Average Price Target Wall Street Target

180 USD 55.24%

SRPT Highest Price Target Wall Street Target

205 USD 77.20%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free